A Caballero

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

Gloria Iacoboni, Guillermo Villacampa, Núria Martínez‐Cibrián et al. · Cancer Medicine · 2021 · 134 citations · Full text

Medicine, Hematology, Oncology +14

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

Mi Kwon, Gloria Iacoboni, Juan Luis Reguera et al. · Haematologica · 2022 · 132 citations · Full text

Medicine, Hematology, Oncology +13

Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study

Semiglazov Vf, W. Eiermann, Milvia Zambetti et al. · European Journal of Surgical Oncology · 2011 · 57 citations

Medicine, Oncology, Surgery +16

Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study

Roser Velasco, Santiago Mercadal, Noemí Vidal et al. · Journal of Neuro-Oncology · 2020 · 56 citations

Medicine, Neurology, Oncology +13

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy

Gloria Iacoboni, Josu Iraola‐Truchuelo, Maeve O’Reilly et al. · HemaSphere · 2024 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17